SEC Filings

SEC Filings

Filing date	Description	Form	View
Apr 03, 2013	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001193125-13-140399.pdf 0001193125-13-140399.rtf 0001193125-13-140399.xls
Apr 03, 2013	An annual report to security holders	ARS	View HTML
Mar 07, 2013	Annual report which provides a comprehensive overview of the company for the past year	10-K	View HTML 0001193125-13-096235.pdf 0001193125-13-096235.rtf 0001193125-13-096235.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Mar 01, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-13-013578.pdf 0001181431-13-013578.rtf
Feb 27, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-079592.pdf 0001193125-13-079592.rtf 0001193125-13-079592.xls
Feb 26, 2013	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-13-011587.pdf 0001209191-13-011587.rtf
Feb 22, 2013	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	View HTML 0001193125-13-069997.pdf 0001193125-13-069997.rtf 0001193125-13-069997.xls
Feb 22, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-070000.pdf 0001193125-13-070000.rtf 0001193125-13-070000.xls
Feb 22, 2013	FWP	FWP	View HTML 0001193125-13-070478.pdf 0001193125-13-070478.rtf 0001193125-13-070478.xls
Feb 22, 2013	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-13-071684.pdf 0001193125-13-071684.rtf 0001193125-13-071684.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE